Helixmith Overview

  • Founded
  • 1996
  • Status
  • Public
  • Employees
  • 113
  • Stock Symbol
  • 084990
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $15.99
  • (As of Thursday Closing)

Helixmith General Information


Helixmith Co Ltd, formerly ViroMed Co Ltd is active in the healthcare sector in Korea. The company specializes in developing pharmaceutical products for the treatment of diseases related to peripheral artery, coronary artery, cardiovascular system and neuropathy, cancer and allergy. Its suite of products includes protein/deoxyribonucleic acid (DNA)-based biopharmaceuticals, botanical drugs and natural pharmaceuticals.

Contact Information

Formerly Known As
ViroMedica Pacific
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • 5th Floor, Building 203, SNU
  • No. 599 Gwanak-ro, Gwanak-gu
  • Seoul, 151-747
  • South Korea
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Helixmith Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$15.99 $16.85 $15.95 - $34.01 $602M 37.7M 189K -$1.21

Helixmith Financials Summary

In Thousands,
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 570,658 873,599 1,654,302 3,596,774
Revenue 2,202 3,646 3,820 2,845
EBITDA (42,942) (56,390) (87,717) (26,532)
Net Income (41,309) (70,176) (91,793) (26,138)
Total Assets 258,721 438,288 320,662 254,166
Total Debt 25,777 137,093 111,104 73,212
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Helixmith Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Helixmith‘s full profile, request access.

Request a free trial

Helixmith Patents

Helixmith Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200271647-A1 Biomarkers for predicting prognosis of kidney disease Pending 19-Dec-2018 00000000000
EP-3888669-A1 Composition for preventing or treating metabolic bone diseases or menopausal symptoms Pending 28-Nov-2018 0000000000
EP-3882267-A1 Anti-c-met antibody showing enhanced stability or antigen-binding fragments thereof Pending 14-Nov-2018 00000000000
US-20200023075-A1 Lyophilized pharmaceutical compositions for naked dna gene therapy Pending 19-Jul-2018 00000000
CA-3106297-A1 Lyophilized pharmaceutical compositions for naked dna gene therapy Pending 19-Jul-2018 A61K48/0091
To view Helixmith’s complete patent history, request access »

Helixmith Executive Team (3)

Name Title Board Seat Contact Info
Yongsoo Kim President & Chief Executive Officer
Jong-Mook Kim Ph.D Founder, Chief Executive Officer & Board Member
Sunyoung Kim Ph.D Co-Founder & Chief Scientific Officer, Research & Development Center
To view Helixmith’s complete executive team members history, request access »

Helixmith Board Members (1)

Name Representing Role Since
Jong-Mook Kim Ph.D Helixmith Founder, Chief Executive Officer & Board Member 000 0000
To view Helixmith’s complete board members history, request access »

Helixmith Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Helixmith Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 (000 00 20-Aug-2018 000000000 Buildings and Property 00000000
Wacker Biotech US 01-Aug-2018 Joint Venture BPO/Outsource Services
To view Helixmith’s complete investments history, request access »

Helixmith Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 0000000 00 01-Aug-2018 00000 0000000 Completed
  • 2 buyers
To view Helixmith’s complete exits history, request access »